Day One | Targeted Therapies for Patients of All Ages

Now FDA approved
in the U.S.

Ready to make an impact.

We are working hard to bring novel targeted therapies to children with brain tumors and potentially others who can benefit.

Show me more

Advancing Pediatric Cancer Research and Drug Development Through Multistakeholder Collaboration

By sharing this Framework, we hope to prompt further discussions and greater collaboration to advance pediatric cancer research and drug development. It is one step in the right direction. We look forward to building upon our learnings, evolving the Framework, and working together to change the outlook for children with cancer and their families.

Download the whitepaper